France· FR:66383154
MAGNEVIE B6 100 mg/10 mg, comprimé pelliculé
A medicinal product containing chlorhydrate de pyridoxine + magnésium (citrate de) anhydre, registered in France by OPELLA HEALTHCARE FRANCE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE PYRIDOXINE + MAGNÉSIUM (CITRATE DE) ANHYDRE
- Manufacturer
- OPELLA HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
- cip133400936326866plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)
- cip1334009498905452 plaquette(s) PVC polyéthylène PVDC aluminium de 60 comprimé(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de pyridoxine + magnésium (citrate de) anhydre in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandAsmag B6 FortePrzedsiębiorstwo Farmaceutyczne Farmapol Sp. z o.o.
- CzechiaMAGNE B6Opella Healthcare Czech s.r.o., Praha
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Bulgaria · Магне B6
- Czechia · Magne B6
- Estonia · Magne B6
- Greece · Evrima-B6
- Hungary · Magne B6, Magne B6 Forte
- Lithuania · Magne B6
- Latvia · Magne B6, Magne B6 Premium
- Malta · Magnevie B6
- Poland · Asmag B6 Forte, Laktomag B6
- Romania · Magne B6, Magne B6 Forte
- Slovakia · Magne B6
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/838a7dae-5b99-46c2-81ef-cd02c3bd261f GET /v1/drugs/838a7dae-5b99-46c2-81ef-cd02c3bd261f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66383154",
"date_amm": "2004-05-10",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "CHLORHYDRATE DE PYRIDOXINE + MAGNÉSIUM (CITRATE DE) ANHYDRE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de pyridoxine + magnésium (citrate de) anhydre.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.